Implementation of the Prostate Cancer Guideline into practice
No development in medicine, no matter how advanced it may be, is effective if it does not reach the patient. This makes it all the more important for the professional association of German urologists (BDU) to act quickly and to put the new S3 guideline for the treatment of prostate cancer into practice. With a nationwide training initiative, the knowledge about early detection, diagnosis and therapy, which is currently available, is to be passed on to all urologists in Germany. The stated aim of the BDU is to ensure that patients benefit as quickly as possible from the innovations of the guideline and receive "best possible treatment in line with the guideline", emphasised Dr. Martin Bloch, president of the professional association.
The most important results formulated in the S3 guideline include
- PSA determination from 40 years on
- Increased obligation to inform about diagnosis and therapy by the treating urologist
- Active monitoring as an equivalent treatment option for localized prostate cancer with a low risk profile
- Lower incontinence and impotence rates in brachytherapy compared to radical prostatectomy
- Cryotherapy and HIFU are not justified as treatment alternatives according to current data.
Conclusion for the practice
Today, more than 70 percent of all diagnosed prostate carcinomas are in an organ-limited and therefore potentially curable stage. Thanks to improved early detection methods, however, carcinomas are also discovered that would otherwise have been unrecognized and could have posed no problems for life,"explains Dr. Pedram Derakhshani. Against this backdrop, treatment options such as brachytherapy or defensive strategies such as active monitoring are gaining in importance,"said the urologist from the West German Prostate Center. The current S3 guideline takes this development into account in its recommendations by placing a special focus on the quality of life of patients and thus on treatment methods with few side effects.